Digital Biotech on pre-clinical study for new anti-Arzheimer drug.

Digital Biotech Inc. has launched a pre-clinical study for the new candidated drug in the treatment of Arzheimeer disease, The mode of the drug action blocks an aggregation of toxic protein called beta-amyloids and detoxifies the aggregated proteins found in the brain of the Arzheimer patients.

Digital Biotech was nominated and supported by the Korea Health Industry Development Institute (KH...